6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
5m ago	Colgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
31m ago	Navios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
32m ago	Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
32m ago	Fiverr Announces First Quarter 2026 Results

About

Formosa Pharmaceuticals, Inc. (TW:6838) — investor relations, events, news, and company updates on 6ix.

Latest News

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

Financials

Revenue

NT$9.49 M

Market Cap

NT$4.22 B

EPS

-0.55

Community Chat

Ask AI